← All stocks

Amphastar Pharmaceuticals, Inc.

AMPH Net selling
CIK 0001297184 #2610 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$75.31K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$75.31K
1 of 1 sales
Net
−$75.31K
−$75.31K against sales at will

By person

12 insiders · 1 transaction
105×

Jack Yongfeng Zhang holds 105 times base salary in stock. $100.07M of shares against $950.91K in salary for 2025.

Salary from the company's own proxy. The shares are what Jack Yongfeng Zhang last reported holding, valued at $23.63, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Zhou Rong
SENIOR EVP, PRODUCTION CENTER
$75.31K (1)
−$75.31K
349,197
0.8209%
$8.25M
+16.5%
Zhang Jack Y.
CEO & CHIEF SCIENTIFIC OFFICER
4,235,177
9.96%
$100.07M
+9.6%
PETERS WILLIAM J
CFO, EVP & TREASURER
172,846
0.4063%
$4.08M
+80.9%
Lee Howard
Director
159,350
0.3746%
$3.77M
+7.8%
Liawatidewi Yakob
EVP CORP ADMIN CENTER
121,892
0.2865%
$2.88M
+61.5%
Petersen Floyd F.
Director
71,368
0.1678%
$1.69M
−5.4%
ZASLOFF MICHAEL A
Director
37,667
0.0885%
$890.04K
+54.4%
Gerst Diane G.
Director
31,899
0.0750%
$753.74K
+71.2%
PRINS RICHARD K
Director
29,625
0.0696%
$700.01K
+4.9%
Deflin Gayle
Director
19,057
0.0448%
$450.30K
+229.0%
Gaugh David Russell
Director
14,447
0.0340%
$341.37K
Pierce Anthony T
Director
7,886
0.0185%
$186.34K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 0
History held since 2 Sep 2016